Logo image of ERO

ERO COPPER CORP (ERO) Stock Fundamental Analysis

USA - NYSE:ERO - CA2960061091 - Common Stock

21.84 USD
+0.2 (+0.92%)
Last: 10/7/2025, 7:23:02 PM
21.8 USD
-0.04 (-0.18%)
After Hours: 10/7/2025, 7:23:02 PM
Fundamental Rating

5

ERO gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 156 industry peers in the Metals & Mining industry. ERO scores excellent on profitability, but there are concerns on its financial health. ERO is evaluated to be cheap and growing strongly. This does not happen too often!


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

In the past year ERO was profitable.
ERO had a positive operating cash flow in the past year.
ERO had positive earnings in 4 of the past 5 years.
In the past 5 years ERO always reported a positive cash flow from operatings.
ERO Yearly Net Income VS EBIT VS OCF VS FCFERO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

ERO has a Return On Assets of 8.05%. This is amongst the best in the industry. ERO outperforms 85.26% of its industry peers.
With an excellent Return On Equity value of 17.33%, ERO belongs to the best of the industry, outperforming 90.38% of the companies in the same industry.
With an excellent Return On Invested Capital value of 9.33%, ERO belongs to the best of the industry, outperforming 80.77% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ERO is below the industry average of 12.16%.
The 3 year average ROIC (8.14%) for ERO is below the current ROIC(9.33%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.05%
ROE 17.33%
ROIC 9.33%
ROA(3y)3.34%
ROA(5y)9.91%
ROE(3y)6.26%
ROE(5y)18.84%
ROIC(3y)8.14%
ROIC(5y)19.2%
ERO Yearly ROA, ROE, ROICERO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

ERO has a better Profit Margin (26.62%) than 91.03% of its industry peers.
With an excellent Operating Margin value of 32.35%, ERO belongs to the best of the industry, outperforming 84.62% of the companies in the same industry.
In the last couple of years the Operating Margin of ERO has remained more or less at the same level.
ERO has a Gross Margin of 42.71%. This is amongst the best in the industry. ERO outperforms 80.77% of its industry peers.
In the last couple of years the Gross Margin of ERO has remained more or less at the same level.
Industry RankSector Rank
OM 32.35%
PM (TTM) 26.62%
GM 42.71%
OM growth 3Y-22.63%
OM growth 5Y-1.37%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.13%
GM growth 5Y-1.36%
ERO Yearly Profit, Operating, Gross MarginsERO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ERO is creating some value.
ERO has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ERO has been increased compared to 5 years ago.
The debt/assets ratio for ERO is higher compared to a year ago.
ERO Yearly Shares OutstandingERO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ERO Yearly Total Debt VS Total AssetsERO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

ERO has an Altman-Z score of 2.52. This is not the best score and indicates that ERO is in the grey zone with still only limited risk for bankruptcy at the moment.
ERO has a Altman-Z score (2.52) which is in line with its industry peers.
A Debt/Equity ratio of 0.70 indicates that ERO is somewhat dependend on debt financing.
ERO has a Debt to Equity ratio of 0.70. This is amonst the worse of the industry: ERO underperforms 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF N/A
Altman-Z 2.52
ROIC/WACC1.08
WACC8.67%
ERO Yearly LT Debt VS Equity VS FCFERO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 0.84 indicates that ERO may have some problems paying its short term obligations.
ERO's Current ratio of 0.84 is on the low side compared to the rest of the industry. ERO is outperformed by 89.10% of its industry peers.
ERO has a Quick Ratio of 0.84. This is a bad value and indicates that ERO is not financially healthy enough and could expect problems in meeting its short term obligations.
ERO has a Quick ratio of 0.52. This is amonst the worse of the industry: ERO underperforms 89.74% of its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.52
ERO Yearly Current Assets VS Current LiabilitesERO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 71.23% over the past year.
The Earnings Per Share has been decreasing by -2.60% on average over the past years.
Looking at the last year, ERO shows a very strong growth in Revenue. The Revenue has grown by 20.59%.
The Revenue has been growing by 10.55% on average over the past years. This is quite good.
EPS 1Y (TTM)71.23%
EPS 3Y-30.56%
EPS 5Y-2.6%
EPS Q2Q%155.56%
Revenue 1Y (TTM)20.59%
Revenue growth 3Y-1.36%
Revenue growth 5Y10.55%
Sales Q2Q%39.63%

3.2 Future

The Earnings Per Share is expected to grow by 21.30% on average over the next years. This is a very strong growth
Based on estimates for the next years, ERO will show a quite strong growth in Revenue. The Revenue will grow by 11.24% on average per year.
EPS Next Y163.4%
EPS Next 2Y88.5%
EPS Next 3Y56.19%
EPS Next 5Y21.3%
Revenue Next Year57.74%
Revenue Next 2Y43.85%
Revenue Next 3Y27.97%
Revenue Next 5Y11.24%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ERO Yearly Revenue VS EstimatesERO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
ERO Yearly EPS VS EstimatesERO Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

ERO is valuated rather expensively with a Price/Earnings ratio of 17.47.
Based on the Price/Earnings ratio, ERO is valued cheaper than 87.18% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.76, ERO is valued a bit cheaper.
ERO is valuated cheaply with a Price/Forward Earnings ratio of 7.88.
Based on the Price/Forward Earnings ratio, ERO is valued cheaper than 96.15% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.21, ERO is valued rather cheaply.
Industry RankSector Rank
PE 17.47
Fwd PE 7.88
ERO Price Earnings VS Forward Price EarningsERO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

ERO's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ERO is cheaper than 74.36% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.91
ERO Per share dataERO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ERO has an outstanding profitability rating, which may justify a higher PE ratio.
ERO's earnings are expected to grow with 56.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.11
PEG (5Y)N/A
EPS Next 2Y88.5%
EPS Next 3Y56.19%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ERO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ERO COPPER CORP

NYSE:ERO (10/7/2025, 7:23:02 PM)

After market: 21.8 -0.04 (-0.18%)

21.84

+0.2 (+0.92%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners74.32%
Inst Owner Change0%
Ins Owners6.14%
Ins Owner ChangeN/A
Market Cap2.26B
Analysts81.11
Price Target19.13 (-12.41%)
Short Float %4.37%
Short Ratio5.54
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)43.75%
Min EPS beat(2)11.2%
Max EPS beat(2)76.3%
EPS beat(4)2
Avg EPS beat(4)6.18%
Min EPS beat(4)-44.95%
Max EPS beat(4)76.3%
EPS beat(8)4
Avg EPS beat(8)7.42%
EPS beat(12)5
Avg EPS beat(12)-2.7%
EPS beat(16)6
Avg EPS beat(16)-5.04%
Revenue beat(2)0
Avg Revenue beat(2)-5.09%
Min Revenue beat(2)-6.41%
Max Revenue beat(2)-3.77%
Revenue beat(4)0
Avg Revenue beat(4)-11.95%
Min Revenue beat(4)-20.39%
Max Revenue beat(4)-3.77%
Revenue beat(8)1
Avg Revenue beat(8)-7.79%
Revenue beat(12)3
Avg Revenue beat(12)-6.75%
Revenue beat(16)5
Avg Revenue beat(16)-5.93%
PT rev (1m)1.01%
PT rev (3m)-0.23%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-8.87%
EPS NY rev (1m)0.09%
EPS NY rev (3m)-4.52%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.05%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)-5.31%
Valuation
Industry RankSector Rank
PE 17.47
Fwd PE 7.88
P/S 4.22
P/FCF N/A
P/OCF 8.41
P/B 2.75
P/tB 2.75
EV/EBITDA 10.91
EPS(TTM)1.25
EY5.72%
EPS(NY)2.77
Fwd EY12.69%
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)2.6
OCFY11.9%
SpS5.17
BVpS7.95
TBVpS7.95
PEG (NY)0.11
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.05%
ROE 17.33%
ROCE 11.11%
ROIC 9.33%
ROICexc 9.75%
ROICexgc 9.75%
OM 32.35%
PM (TTM) 26.62%
GM 42.71%
FCFM N/A
ROA(3y)3.34%
ROA(5y)9.91%
ROE(3y)6.26%
ROE(5y)18.84%
ROIC(3y)8.14%
ROIC(5y)19.2%
ROICexc(3y)9.9%
ROICexc(5y)23.79%
ROICexgc(3y)9.9%
ROICexgc(5y)23.79%
ROCE(3y)9.69%
ROCE(5y)22.87%
ROICexcg growth 3Y-45.44%
ROICexcg growth 5Y-14.21%
ROICexc growth 3Y-45.44%
ROICexc growth 5Y-14.21%
OM growth 3Y-22.63%
OM growth 5Y-1.37%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.13%
GM growth 5Y-1.36%
F-Score7
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF N/A
Debt/EBITDA 2.23
Cap/Depr 333.17%
Cap/Sales 53.24%
Interest Coverage 4.47
Cash Conversion 103.91%
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.52
Altman-Z 2.52
F-Score7
WACC8.67%
ROIC/WACC1.08
Cap/Depr(3y)480.9%
Cap/Depr(5y)425.39%
Cap/Sales(3y)82.97%
Cap/Sales(5y)64.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)71.23%
EPS 3Y-30.56%
EPS 5Y-2.6%
EPS Q2Q%155.56%
EPS Next Y163.4%
EPS Next 2Y88.5%
EPS Next 3Y56.19%
EPS Next 5Y21.3%
Revenue 1Y (TTM)20.59%
Revenue growth 3Y-1.36%
Revenue growth 5Y10.55%
Sales Q2Q%39.63%
Revenue Next Year57.74%
Revenue Next 2Y43.85%
Revenue Next 3Y27.97%
Revenue Next 5Y11.24%
EBIT growth 1Y92.66%
EBIT growth 3Y-23.68%
EBIT growth 5Y9.03%
EBIT Next Year194.25%
EBIT Next 3Y61.44%
EBIT Next 5Y24.76%
FCF growth 1Y93.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y80.87%
OCF growth 3Y-26.39%
OCF growth 5Y2.62%